Medicare and Parkinson’s Disease: Complete Coverage Guide

Medicare coverage for Parkinson’s disease is more specific than most beneficiaries realize. The LSVT BIG and LSVT LOUD therapy protocols — designed expressly for Parkinson’s movement and voice symptoms — are covered under Part B when prescribed. Deep brain stimulation surgery is covered. Even the cornerstone drug, carbidopa/levodopa, illustrates how tailored the rules get: it starts as an inexpensive Part D generic, then can shift to Part B entirely when advanced disease calls for pump-delivered Duopa.

The harder problem is coordination. Parkinson’s care spans a neurologist, three separate therapy disciplines, durable medical equipment, and eventually home health or skilled nursing — each with its own rules and cost-sharing that shift as the disease progresses. This guide organizes all of it by part of Medicare, following the arc from diagnosis onward.

Parkinson’s and Medicare Eligibility

Most people with Parkinson’s reach Medicare eligibility at age 65 in the standard way. However, Parkinson’s disease is listed as a qualifying condition for Social Security Disability Insurance (SSDI), and people who develop the disease earlier in life can receive Medicare after receiving SSDI for 24 months regardless of age.

If you or a loved one was diagnosed with Parkinson’s before 65 and is unable to work, filing for SSDI should be among the first financial planning steps — approval opens the door to Medicare coverage years ahead of standard eligibility.

Neurologist Visits Under Part B

The neurologist is the central specialist for Parkinson’s care. Medicare Part B covers outpatient neurologist visits as physician services, subject to the Part B deductible ($283 in 2026) and 20% coinsurance after the deductible is met. If you have a Medigap plan, that 20% is typically covered, making specialist visits effectively free after the deductible.

Movement Disorder Specialists

Movement disorder specialists — neurologists who have completed additional fellowship training focused on Parkinson’s and related conditions — bill under the same Part B physician codes as general neurologists. There is no additional Medicare restriction on seeing a subspecialist. Because Parkinson’s is a complex, progressive condition, seeking care from a movement disorder specialist (often found at academic medical centers and Parkinson’s Foundation Centers of Excellence) can improve outcomes without changing your coverage.

Telemedicine Visits

Post-pandemic, Medicare permanently expanded telehealth access for neurology visits. As of 2025, you can see your neurologist via video for most follow-up visits regardless of your geographic location. This is particularly valuable as Parkinson’s progresses and travel becomes more difficult. Your provider must be enrolled in Medicare and you must have an established patient relationship (a prior in-person visit within three years for most services).

Rehabilitation Therapies Under Part B

Parkinson’s disease causes progressive motor dysfunction — tremor, rigidity, bradykinesia, postural instability — that responds well to targeted rehabilitation. Medicare Part B covers three types of outpatient therapy when medically necessary:

Physical Therapy

Physical therapy (PT) addresses gait, balance, strength, and fall prevention. For people with Parkinson’s, evidence-based PT programs like LSVT BIG (a high-amplitude movement training protocol) are covered when prescribed by a physician and delivered by a Medicare-enrolled PT.

Medicare does not impose a fixed annual cap on Part B therapy, but it does apply a threshold (approximately $2,480 in 2026 combined for PT and speech-language pathology). Above this threshold, your therapist must certify that continued treatment is medically necessary. For most people with Parkinson’s, ongoing PT is clearly medically necessary, and this documentation requirement is typically routine.

Occupational Therapy

Occupational therapy (OT) covers daily living skills — dressing, bathing, writing, using utensils — that Parkinson’s affects as it progresses. OT also includes home safety assessments, which are valuable for identifying fall hazards before an injury occurs. OT is billed under a separate cap (approximately $2,480 in 2026) from PT and speech therapy.

Speech-Language Pathology

Parkinson’s frequently causes hypophonia (reduced voice volume) and dysphagia (swallowing difficulty). Speech-language pathology (SLP) addresses both. The LSVT LOUD protocol — intensive voice therapy designed specifically for Parkinson’s — is covered by Part B when prescribed and delivered by a Medicare-enrolled SLP. For dysphagia, SLP includes swallowing studies and techniques to reduce aspiration risk, which is a leading cause of pneumonia-related hospitalization in advanced Parkinson’s.

SLP shares the ~$2,480 cap with PT (not OT), so coordinating these services to stay within the threshold before invoking the medical necessity exception is worth discussing with your care team.

Medications Under Part D

Parkinson’s disease is treated primarily with medications that either replace or mimic dopamine. These drugs fall under Medicare Part D, not Part B, with one important exception noted below.

Levodopa/Carbidopa Combinations

Levodopa (combined with carbidopa to reduce side effects) is the cornerstone of Parkinson’s treatment. Brand names include Sinemet, Rytary, and Duopa. Generic carbidopa/levodopa is widely available and typically falls in a low-cost tier on most Part D formularies. Extended-release formulations like Rytary cost more and may require step therapy (trying generic first) before the plan covers the brand.

Duopa is carbidopa/levodopa delivered continuously via a jejunal tube for patients with advanced Parkinson’s who experience severe motor fluctuations. Because it is delivered via infusion through implanted tubing, Duopa may be covered under Part B (durable medical equipment / infusion pump provision) rather than Part D. This distinction matters significantly for cost-sharing — confirm with your Part D plan and your Medicare Administrative Contractor if this therapy is being considered.

MAO-B Inhibitors

Selegiline, rasagiline (Azilect), and safinamide (Xadago) inhibit the MAO-B enzyme to prolong dopamine activity. Selegiline is generic and inexpensive. Rasagiline and safinamide are brand-name only (as of 2025) and fall into mid-to-high cost tiers. Checking formulary placement and requesting a tier exception if your plan doesn’t cover your prescribed brand is worth pursuing — these exceptions are granted when the formulary alternative was tried and failed or is contraindicated.

COMT Inhibitors

Entacapone (Comtan) and opicapone (Ongentys) extend levodopa activity by blocking its breakdown. Tolcapone (Tasmar) is used less commonly due to liver toxicity monitoring requirements. These are covered under Part D; entacapone is generic and low-cost.

Dopamine Agonists

Pramipexole (Mirapex) and ropinirole (Requip) are both available as generics and affordable under Part D. Rotigotine (Neupro) is a patch formulation (still brand-name) in a higher tier. Apomorphine (Kynmobi, Apokyn) is used for acute “off” episodes and is brand-name — coverage and cost-sharing vary significantly by plan.

Part D Cost Management

As Parkinson’s advances, polypharmacy is common. Review your Part D plan’s formulary annually during Open Enrollment (October 15 – December 7). Use Medicare’s Plan Finder tool (medicare.gov/plan-compare) to enter all your medications and compare total annual drug costs across available plans in your area. People with Parkinson’s often benefit significantly from switching plans annually as their medication regimen changes.

The Extra Help (Low Income Subsidy) program reduces Part D premiums, deductibles, and copayments for people with limited income and assets. See our guide to Medicare Savings Programs for eligibility thresholds.

Deep Brain Stimulation Surgery

Deep brain stimulation (DBS) is a surgical therapy for advanced Parkinson’s — electrodes implanted in specific brain structures deliver electrical stimulation that reduces motor symptoms. DBS is FDA-approved for Parkinson’s and is covered by Medicare.

Part A Coverage for DBS

DBS surgery requires inpatient hospitalization. Medicare Part A covers the inpatient stay: the first 60 days after the Part A deductible ($1,736 in 2026 per benefit period), days 61–90 at a daily coinsurance rate, and up to 60 lifetime reserve days beyond 90.

The battery (implantable pulse generator) in a DBS system typically requires replacement every 3–5 years. Each replacement surgery is a separate inpatient admission covered under Part A.

Part B Coverage for DBS Programming

After implantation, the DBS system must be programmed and adjusted over time — a process that continues for months as the optimal stimulation parameters are found. These programming visits are outpatient neurologist visits covered under Part B at 20% coinsurance after the deductible.

Focused Ultrasound

Incisionless focused ultrasound (FUS) is an emerging alternative to DBS for essential tremor and tremor-dominant Parkinson’s. FDA approval for essential tremor is established; Medicare coverage for FUS specifically for Parkinson’s tremor has expanded since 2024 via national coverage determinations — check current Medicare LCD (Local Coverage Determination) from your MAC for the latest status.

Durable Medical Equipment

As Parkinson’s progresses, durable medical equipment (DME) becomes increasingly important. Medicare Part B covers DME when prescribed by a physician and purchased from a Medicare-enrolled DME supplier.

Mobility Aids

Canes and walkers: Standard walkers and rollators (wheeled walkers with brakes and seats) are covered as DME. Medicare covers 80% of the approved amount; you pay 20% plus any excess charge.
Wheelchairs: Manual and power wheelchairs are covered when prescribed as medically necessary. Power wheelchairs require a face-to-face evaluation with your physician documenting that you cannot self-propel a manual chair. Medicare has strict documentation requirements for power mobility — work with your neurologist to ensure the prescription and medical records support the need.
Scooters (POVs): Power-operated vehicles are covered under the same criteria as power wheelchairs.

Other DME

Hospital beds: Covered when needed for in-home use due to mobility limitations or aspiration risk (head elevation).
Grab bars and bath safety equipment: Generally not covered by Medicare — these are considered home modifications rather than medical equipment. Some Medicare Advantage plans include home modification benefits; check your plan’s supplemental benefits.
CPAP machines: Parkinson’s is associated with sleep disorders including REM sleep behavior disorder. If a sleep study confirms obstructive sleep apnea, CPAP is covered under Part B.

Home Health Care

When Parkinson’s limits your ability to leave home without considerable effort, you may qualify for Medicare-covered home health services under Part B (no deductible or coinsurance for Medicare-approved home health). Qualifying requires:

You are homebound (leaving home requires taxing effort or assistance)
You need skilled nursing care, physical therapy, speech therapy, or occupational therapy
A physician certifies a plan of care
The home health agency is Medicare-certified

Home health can include nursing visits, PT, OT, and SLP delivered in your home — the same therapies covered in outpatient settings, but brought to you. This is particularly valuable during hospitalization recovery or when disease progression makes travel to outpatient therapy impractical.

Inpatient Hospital and Skilled Nursing Facility Care

Parkinson’s patients are hospitalized at higher rates than the general population — for DBS surgery, aspiration pneumonia, urinary tract infections, and falls. Each hospitalization is covered under Part A with the benefit-period deductible and coinsurance structure.

After a qualifying inpatient stay of at least three days, Medicare-covered skilled nursing facility (SNF) care is available for up to 100 days per benefit period if skilled care (PT, OT, IV medications, wound care) is still needed. Days 1–20 are fully covered; days 21–100 require a daily coinsurance ($217/day in 2026). If you have a Medigap Plan covering SNF coinsurance (Plans C, D, F, G, M, N — plans that include this benefit), those days are covered.

Medicare Advantage Considerations for Parkinson’s Patients

Medicare Advantage (MA) plans cover all the same services as Original Medicare but typically with different cost-sharing structures and network restrictions. For Parkinson’s patients, several MA plan features deserve scrutiny:

Network access: Movement disorder specialists are often at academic medical centers that may not be in all MA networks. Before enrolling in an MA plan, confirm your neurologist and any specialist at a teaching hospital is in-network.

Prior authorization: MA plans frequently require prior authorization for physical therapy (especially high-visit protocols like LSVT), DME, and procedures. This adds administrative burden and can delay care.

Supplemental benefits: Some MA plans offer supplemental benefits not covered by Original Medicare — fitness memberships, home safety modifications, transportation, hearing aids — that can be valuable for people with Parkinson’s.

Special Needs Plans (SNPs): Some MA plans are Chronic Condition Special Needs Plans (C-SNPs) specifically designed for people with neurological conditions. These plans may have more generous coverage for Parkinson’s-related services.

For a detailed comparison of Original Medicare vs. Medicare Advantage, see our guide to Medicare Advantage vs. Original Medicare.

Caregiver and Family Considerations

Medicare covers services for the person with Parkinson’s, not their unpaid family caregivers. However, several Medicare benefits support caregivers indirectly:

Home health respite: While Medicare does not cover standalone respite care (time off for caregivers), hospice under Part A does include up to five consecutive days of inpatient respite per benefit period when the hospice patient is in the terminal stages of illness.
Cognitive assessment: Medicare’s Annual Wellness Visit includes a cognitive assessment. Given that Parkinson’s dementia affects roughly 50–80% of people with Parkinson’s over time, this screening is valuable for early detection.
Social work: Medicare covers medical social work services as part of home health and hospice, which can connect caregivers to community resources.

The Parkinson’s Foundation (parkinson.org) and Michael J. Fox Foundation (michaeljfox.org) both provide caregiver resources, local support groups, and care navigator services at no cost.

Building a Financial Plan Around Parkinson’s Care

Given the progressive nature of the disease and the multi-decade time horizon for many patients, early financial planning is essential:

Enroll in Medigap as soon as possible: Medigap plans (specifically Plans G and N in most states) significantly reduce out-of-pocket exposure for the high utilization Parkinson’s produces. Guaranteed issue rights apply at Initial Enrollment — after that, medical underwriting can result in denial or higher premiums. See our guide to Medigap plans.
Review Part D annually: As your medication regimen changes, plan formulary placement changes. The Medicare Plan Finder comparison at Open Enrollment is worth the 30 minutes it takes.
Consider long-term care insurance early: LTC insurance — which covers home care, assisted living, and nursing home costs not covered by Medicare — becomes unaffordable or uninsurable as Parkinson’s advances. If you or a family member has a Parkinson’s diagnosis, insurability windows close quickly. See our guide to long-term care insurance.
Understand IRMAA: If your income exceeds the IRMAA thresholds, your Part B and Part D premiums increase significantly. For people who retire due to Parkinson’s, income typically drops — file Form SSA-44 to request an IRMAA reduction based on the life-changing event of stopping work. See our guide to IRMAA appeals.

Key Takeaways

Medicare provides substantial coverage for Parkinson’s disease management across all stages:

Part B covers neurologist visits, PT/OT/SLP therapy, DBS programming, and most DME
Part A covers hospitalizations, DBS surgery, and post-hospital skilled nursing facility care
Part D covers levodopa combinations, MAO-B inhibitors, COMT inhibitors, and dopamine agonists
Home health is available when you become homebound

Gaps exist in home modifications, extended home care not meeting the skilled care threshold, and caregiver support. Medigap coverage is strongly recommended to limit exposure to the 20% Part B coinsurance on high-utilization services.

Early enrollment decisions — especially Medigap timing — have lasting financial consequences for people with Parkinson’s. If you have questions about how your specific situation maps to Medicare coverage, a Medicare counselor through your State Health Insurance Assistance Program (SHIP) can provide free personalized guidance.

Sources

All sources are official government or nonprofit consumer resources, verified July 2026. Medicare and Social Security rules and dollar amounts change annually — confirm current figures at the links above before making decisions.

Medicare and Parkinson's Disease: Complete Coverage Guide